Judith H. Harmey – författare
Visar alla böcker från författaren Judith H. Harmey. Handla med fri frakt och snabb leverans.
2 produkter
2 produkter
Inbunden, Engelska, 2004
899 kr
Skickas inom 10-15 vardagar
"VEGF and Cancer" is a comprehensive and up to date review of current knowledge on the role of vascular endothelial growth factor (VEGF) in cancer. Key features include: discussion of VEGF as potent angiogenic factor and its role in tumor angiogenesis; review of the biology, molecular properties and regulation of VEGF; discussion of the role of VEGF in a range of different tumor types, both solid tumors and haematological cancers; review of the therapeutic potential of different approaches to block VEGF; review of recent evidence that in addition to its role as an endothelial cell mitogen; VEGF may also be an autocrine growth factor for tumor cells; and regulating survival and invasion. This book is aimed at scientists new to angiogenesis and VEGF biology and provides new information for established researchers and scientists. It will also be a useful text for clinicians interested in anti-angiogenic therapy for treatment of human cancers.
Häftad, Engelska, 2012
565 kr
Skickas inom 10-15 vardagar
VEGF and Cancer is a comprehensive and up to date review of current knowledge on the role of vascular endothelial growth factor (VEGF) in cancer. Key Features: -Discussion of VEGF as potent angiogenic factor and its role in tumor angiogenesis, -Review of the biology, molecular properties and regulation of VEGF, -Discussion of the role of VEGF in a range of different tumor types, both solid tumors and haematological cancers, -Review of the therapeutic potential of different approaches to block VEGF, -Review of recent evidence that in addition to its role as an endothelial cell mitogen, VEGF may also be an autocrine growth factor for tumor cells, regulating survival and invasion. This book is aimed at scientists new to angiogenesis and VEGF biology and provides new information for established researchers and scientists. It will also be a useful text for clinicians interested in anti-angiogenic therapy for treatment of human cancers.